As filed with the Securities and Exchange Commission on March 5, 2021

Registration No. 333-



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933

Kadmon Holdings, Inc.
(Exact name of registrant as specified in its charter)



 

 

Delaware
(State or other jurisdiction of
incorporation or organization)

 

27-3576929
(I.R.S. Employer
Identification No.)



450 East 29th Street10016
New York, NY

(Address of principal executive offices)(Zip code)



AMENDED AND RESTATED 2016 EQUITY INCENTIVE PLAN

(Full title of the plan)



Harlan W. Waksal, M.D.
President and Chief Executive Officer

Kadmon Holdings, Inc.
450 East 29th Street
New York, NY 10016
(833)  900-5366
(Name, address, and telephone number, including area code, of agent for service)



 

Copies to:

Eric W. Blanchard, Esq.

Cooley LLP
55 Hudson Yards

New York, NY 10001

(212) 479-6565

Gregory S. Moss, Esq.
General Counsel

Kadmon Holdings, Inc.
450 East 29th Street
New York, NY 10016
(833)  900-5366



Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.



 

 

 

 

 

 

 

 

Large accelerated filer 

 

Accelerated filer 

 

Non-accelerated filer 

 

Smaller reporting company 

 

Emerging growth company 



If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.





 

 


 

CALCULATION OF REGISTRATION FEE



 

 

 

 



 

 

 

 

Title of Securities to  be Registered

Amount to be Registered (1)

Proposed Maximum Offering Price Per Share (2)

Proposed Maximum Aggregate Offering Price (2)

Amount of Registration Fee (2)

Common stock, par value $0.001 per share, issuable pursuant to:

 

 

 

 

--Amended and Restated 2016 Equity Incentive Plan

6,861,201 (3)

$4.79

$32,865,153 

$3,586

Total

6,861,201

$32,865,153

$3,586



 

 

 

 

(1)

Pursuant to Rule 416 of the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional shares of Kadmon Holdings, Inc.’s (the “Registrant”) common stock, par value $0.001 per share (the “Common Stock”), that become issuable under the Registrant’s Amended and Restated 2016 Equity Incentive Plan (the “2016 Equity Plan”) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Common Stock.

(2)

Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) and 457(h) of the Securities Act based on an average of the high and low prices of the Common Stock, as reported on the Nasdaq Global Select Market on March 1, 2021 (rounded to the nearest cent).

(3)

Represents 28,646,939 shares of Common Stock reserved for issuance pursuant to awards under the 2016 Equity Plan. Of these shares, 21,785,738 shares of Common Stock were previously registered by the Registrant on Form S-8 (File No. 333-238972) filed with the Securities and Exchange Commission (the “Commission”) on June 5, 2020, by the Registrant on Form S-8 (File No. 333-233770) filed with the Commission on September 13, 2019  and by the Registrant on Form S-8 filed with the Commission on September 22, 2016 (File No. 333-213748).





 

 

 


 

EXPLANATORY NOTE

This registration statement on Form S-8 (the “Registration Statement”) is being filed by the Registrant for the purpose of registering additional shares of its Common Stock issuable under the Registrant’s Amended and Restated 2016 Equity Incentive Plan. Accordingly, the content of the Registrant’s registration statement on Form S-8 filed with the Commission on June 5, 2020 (File No. 333-238972), September 13, 2019 (File No. 333-233770) and September 22, 2016 (File No. 333-213748) is incorporated by reference into this Registration Statement pursuant to General Instruction E of Form S-8.

 

 


 



PART II

 

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT 

 

Item 3. Incorporation of Documents by Reference. 

 

The following documents, which have been filed by the Registrant with the Commission, are incorporated herein by reference: 

 



 

 

 



 

 

The Registrant’s definitive proxy statement on Schedule 14A for the 2020 Annual Meeting of Stockholders, filed with the Commission on April 2, 2020;



 

 

The Registrant’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the Commission on March 4, 2021;



 

 

The Registrant’s Current Reports on Form 8-K filed with the Commission on January 12, 2021, February 10, 2021 (other than any portion thereof deemed furnished and not filed) and February 16, 2021; and



 

 

The description of the Registrant’s Common Stock contained in its Annual Report on Form 10-K for the year ended December 31, 2020, filed with the Commission on March 4, 2021, including any amendments or reports filed for the purpose of updating such description.



All reports and definitive proxy or information statements field pursuant to Section 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, subsequent to the filing of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which de-registers all securities then remaining unsold shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing such documents, except as to specific sections of such statements as set forth therein. Unless expressly incorporated into this Registration Statement, a report furnished on Form 8-K prior or subsequent to the date hereof shall not be incorporated by reference into this Registration Statement. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement.

 

Item 8. Exhibits. 

    





II-1

 


 

SIGNATURES

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in New York, New York on the 5th day of March, 2021. 





 

Kadmon Holdings, Inc.

By:

/s/ Harlan W. Waksal



Name:    Harlan W. Waksal, M.D.



Title:      President and Chief Executive Officer





KNOW ALL MEN BY THESE PRESENTS, that the undersigned directors and officers of Kadmon Holdings, Inc., a Delaware corporation, constitute and appoint Dr. Harlan W. Waksal and Mr. Steven Meehan, or either of them, the true and lawful agents and attorneys-in-fact of the undersigned with full power and authority in said agents and attorneys-in-fact, to sign for the undersigned in their respective names as directors and officers of Kadmon Holdings, Inc., its Registration Statement on Form S-8, and any amendment (including post-effective amendments) or supplement thereto, relating to the offer and sale of common stock of the Company pursuant to the Amended and Restated 2016 Equity Incentive Plan of Kadmon Holdings, Inc., to be filed with the Commission under the Securities Act. We hereby confirm all acts taken by such agents and attorneys-in-fact, as herein authorized. 

 

Pursuant to the requirements of the Securities Act, this Form S-8 Registration Statement has been signed by the following persons in the capacities and on the date indicated. 





 

 

Signature

Title

Date

/s/ Harlan W. Waksal

President and Chief Executive Officer and Director

March  5, 2021

Harlan W. Waksal, M.D.

(Principal Executive Officer)

 

/s/ Steven Meehan

Executive Vice President and Chief Financial Officer

March  5, 2021

Steven Meehan

(Principal Financial Officer)

 

/s/ Kyle Carver

Senior Vice President, Chief Accounting Officer and Controller

March  5, 2021

Kyle Carver

(Principal Accounting Officer)

 

/s/ Tasos G. Konidaris

Chairman of the Board of Directors

March  5, 2021

Tasos G. Konidaris

 

 

/s/ Eugene Bauer

Director

March  5, 2021

Eugene Bauer

 

 

/s/ David E. Cohen

Director

March  5, 2021

David E. Cohen

 

 

/s/ Arthur Kirsch

Director

March  5, 2021

Arthur Kirsch

 

 

/s/ Nancy Miller-Rich

Director

March  5, 2021

Nancy Miller-Rich

 

 

/s/ Cynthia Schwalm

Director

March  5, 2021

Cynthia Schwalm

 

 





II-2